WANY
VNRX icon

Wealthspire Advisors (New York)’s VolitionRx Ltd VNRX Stock Holding History

Wealthspire Advisors (New York)’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.4K Buy
+11,000
New +$52.5K ﹤0.01% 910

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wealthspire Advisors (New York)'s VNRX Position: Q1 2026 in Review

Wealthspire Advisors (New York) opened a new position in VolitionRx Ltd (VNRX) in Q1 2026: 11,000 shares worth $44.4K. The stake represents ﹤0.01% of the portfolio and ranks #910 among its holdings.

31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Wealthspire Advisors (New York) held 11,000 shares of VolitionRx Ltd worth $44.4K as of Q1 2026.
  • VolitionRx Ltd was a new Wealthspire Advisors (New York) position in Q1 2026.
  • VolitionRx Ltd made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #910 holding.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.